labetalol hydrochloride tablet film coated
INDICATIONS AND USAGE Labetalol hydrochloride tablets, USP are indicated in the management of hypertension. Labetalol hydrochloride tablets USP may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics.
zydus pharmaceuticals (usa) inc.
Related Pills
labetalol hydrochloride tablet film coated
zydus pharmaceuticals (usa) inc.
labetalol 200 mg
american health packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
LABETALOL HYDROCHLORIDE Tablets USP for oral administration are available as:
LABETALOL HYDROCHLORIDE Tablets USP, 100 mg are yellow colored, round, biconvex, film-coated tablets debossed with "7" and "98" on either side of score line on one side and plain on other side and are supplied as: NDC 68382-798-06 in bottle of 30 tablets NDC 68382-798-16 in bottle of 90 tablets NDC 68382-798-01 in bottle of 100 tablets NDC 68382-798-05 in bottle of 500 tablets
LABETALOL HYDROCHLORIDE Tablets USP, 200 mg are white to off white colored, round, biconvex, film-coated tablets debossed with "7" and "99" on either side of score line on one side and plain on other side and are supplied as: NDC 68382-799-06 in bottle of 30 tablets NDC 68382-799-16 in bottle of 90 tablets NDC 68382-799-01 in bottle of 100 tablets NDC 68382-799-05 in bottle of 500 tablets
LABETALOL HYDROCHLORIDE Tablets USP, 300 mg are light green colored, round, biconvex, beveled edge, film-coated tablets debossed with "800" on one side and plain on other side and are supplied as: NDC 68382-800-06 in bottle of 30 tablets NDC 68382-800-16 in bottle of 90 tablets NDC 68382-800-01 in bottle of 100 tablets NDC 68382-800-05 in bottle of 500 tablets
LABETALOL HYDROCHLORIDE Tablets USP should be Stored at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure as required. To report SUSPECTED ADVERSE REACTIONS, contact Zydus Pharmaceuticals USA Inc. at 1-877-993-8779 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. This product's package insert may have been updated. For current package insert, please visit www.zydususa.com Manufactured by: Zydus Lifesciences Ltd. Matoda, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 Rev.: 08/22
More pills like ROUND 7 99